SCHEMBL30689367

SCHEMBL30689367

Cc1nnc(Oc2ccc(-c3noc(CO)n3)cc2)s1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NOTUM Q6P988 2/20 0.50
▸ RAB9A P51151 4/20 0.43
▸ TSHR P16473 4/20 0.43
▸ LMNA P02545 3/20 0.43
▸ NFKB1 P19838 1/20 0.43
▸ NFKB2 Q00653 1/20 0.43
▸ RELA Q04206 1/20 0.43
▸ ATM Q13315 1/20 0.42
▸ ACACB O00763 3/20 0.42
▸ ACACA Q13085 2/20 0.41
▸ L3MBTL1 Q9Y468 4/20 0.41
▸ NPC1 O15118 3/20 0.41
▸ CASP3 P42574 2/20 0.41
▸ SENP8 Q96LD8 2/20 0.41
▸ SENP7 Q9BQF6 2/20 0.41
▸ SENP6 Q9GZR1 2/20 0.41
▸ SIRT2 Q8IXJ6 1/20 0.41
▸ MAPT P10636 4/20 0.40
▸ HTT P42858 2/20 0.40
▸ TDP1 Q9NUW8 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30689384 0.88 TSHR (0.42) RAB9ATSHRLMNANFKB1NFKB2
SCHEMBL30689335 0.84 LMNA (0.49) RAB9ATSHRLMNANFKB1NFKB2
SCHEMBL30689393 0.82 LMNA (0.43) RAB9ATSHRLMNANFKB1NFKB2
SCHEMBL30689309 0.79 LMNA (0.39) RAB9ATSHRLMNANFKB1NFKB2
SCHEMBL8900040 0.76 LMNA (0.66) NOTUMRAB9ATSHRLMNAATM
SCHEMBL6527881 0.74 NOTUM (0.70) NOTUMRAB9ATSHRLMNAATM
SCHEMBL30689308 0.73 MITF (0.36) RAB9ATSHRLMNANFKB1NFKB2
SCHEMBL6528506 0.68 NOTUM (0.66) NOTUMRAB9ATSHRLMNAACACB
SCHEMBL5356293 0.68 NOTUM (1.00) NOTUMRAB9ATSHRNPC1SIRT2
SCHEMBL31049642 0.68 NOTUM (0.70) NOTUMRAB9ATSHRL3MBTL1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119968366-A Oxadiazole derivatives, methods of preparation and use thereof in the treatment of inflammatory diseases 西特瑞治疗有限公司 2025-05-09 — — CN disclosed
EP-4543875-A1 OXADIAZOLE DERIVATIVES, PREPARATION PROCESS THEREOF AND THEIR USE IN TREATING INFLAMMATORY DISEASES Sitryx Therapeutics Limited (GB) 2025-04-30 — — EP disclosed
WO-2023247958-A1 OXADIAZOLE DERIVATIVES, PREPARATION PROCESS THEREOF AND THEIR USE IN TREATING INFLAMMATORY DISEASES SITRYX THERAPEUTICS LIMITED (GB) 2023-12-28 — — WO disclosed
Send feedback